Clinical Impact Of Small TP53 Mutated Subclones In Chronic Lymphocytic Leukemia

被引：1
|
作者：
Rossi, Davide
Khiabanian, Hossein
Ciardullo, Carmela
Spina, Valeria
Bruscaggin, Alessio
Fama, Rosella
Monti, Sara
Rasi, Silvia
Wang, Jiguang
Gattei, Valter
Guarini, Anna
FoA, Robin
Rabadan, Raul
Gaidano, Gianluca
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.116.116
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
116
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
    Rossi, Davide
    Khiabanian, Hossein
    Spina, Valeria
    Ciardullo, Carmela
    Bruscaggin, Alessio
    Fama, Rosella
    Rasi, Silvia
    Monti, Sara
    Deambrogi, Clara
    De Paoli, Lorenzo
    Wang, Jiguang
    Gattei, Valter
    Guarini, Anna
    Foa, Robin
    Rabadan, Raul
    Gaidano, Gianluca
    BLOOD, 2014, 123 (14) : 2139 - 2147
  • [2] Impact of TP53 Mutated Subclones in Acute Myeloid Leukemia
    Pabst, Gabriel
    Prochazka, Katharina
    Pregartner, Gudrun
    Rucker, Frank G.
    Heitzer, Ellen
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Dohner, Konstanze
    Sill, Heinz
    BLOOD, 2018, 132
  • [3] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
    Bomben, Riccardo
    Rossi, Maria Francesca
    D'Agaro, Tiziana
    Bittolo, Tamara
    Zucchetto, Antonella
    Tissino, Erika
    Pozzo, Federico
    Vit, Filippo
    Bulian, Pietro
    Degan, Massimo
    Zaina, Eva
    Cattarossi, Ilaria
    Nanni, Paola
    Chivilo, Hillarj
    D'Arena, Giovanni Francesco
    Chiarenza, Annalisa
    Santinelli, Enrico
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    BLOOD, 2018, 132
  • [4] TP53 Aberrations in Chronic Lymphocytic Leukemia
    Trbusek, Martin
    Malcikova, Jitka
    ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 109 - 131
  • [5] Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
    Ahn, Inhye E.
    Tian, Xin
    Wiestner, Adrian
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 498 - 500
  • [6] TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
    Zenz, Thorsten
    Eichhorst, Barbara
    Busch, Raymonde
    Denzel, Tina
    Haebe, Sonja
    Winkler, Dirk
    Buehler, Andreas
    Edelmann, Jennifer
    Bergmann, Manuela
    Hopfinger, Georg
    Hensel, Manfred
    Hallek, Michael
    Doehner, Hartmut
    Stilgenbauer, Stephan
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4473 - 4479
  • [7] Clinical and Biological Impact of TP53 Alterations in Del(11q) Chronic Lymphocytic Leukemia
    Carretero, Claudia Perez
    Alamo, Miguel Quijada
    Hernandez-Sanchez, Maria
    Rodriguez, Ana E.
    Herrero, Ana B.
    Hernandez-Sanchez, Jesus M.
    Izquierdo, Marta Martin
    Gonzalez, Teresa
    Santos-Minguez, Sandra
    Miguel-Garcia, Cristina
    Rubio-Martinez, Araceli
    de Coca, Alfonso Garcia
    Davila, Julio
    Hernandez, Jose-Angel
    Benito, Rocio
    Ordonez, Jose Luis
    Hernandez-Rivas, Jesus Maria
    BLOOD, 2020, 136
  • [8] Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment
    Brieghel, Christian
    Kinalis, Savvas
    Yde, Christina W.
    Schmidt, Ane Y.
    Jonson, Lars
    Andersen, Michael A.
    da Cunha-Bang, Caspar
    Pedersen, Lone B.
    Geisler, Christian H.
    Nielsen, Finn C.
    Niemann, Carsten U.
    HAEMATOLOGICA, 2019, 104 (04) : 789 - 796
  • [9] The TP53 Codon72 Polymorphism Is Associated with TP53 Mutations in Chronic Lymphocytic Leukemia
    Grossmann, Vera
    Artusi, Valentina
    Schnittger, Susanne
    Dicker, Frank
    Jeromin, Sabine
    Boeck, Lucia
    Haferlach, Torsten
    Haferlach, Claudia
    Kern, Wolfgang
    Kohlmann, Alexander
    BLOOD, 2011, 118 (21) : 778 - 778
  • [10] TP53 Mutation Status in Chronic Lymphocytic Leukemia (CLL)
    Viswanatha, D. S.
    Frederick, L. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 584 - 584
12345